Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series
Sara Bindoli, Paola Galozzi, Andrea Doria, Paolo Sfriso
Topics & Concepts
AnakinraMedicineMacrophage activation syndromeCanakinumabTocilizumabCytokine stormRashRheumatologyInternal medicineDiseasePediatricsIntensive care medicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Autoimmune and Inflammatory Disorders ResearchPediatric health and respiratory diseasesOtitis Media and Relapsing Polychondritis